Log in to save to my catalogue

Urine proteomics-based analysis identifies CHI3L1 as an immune marker and potential therapeutic targ...

Urine proteomics-based analysis identifies CHI3L1 as an immune marker and potential therapeutic targ...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f756f289e2084d27afdb0ae243a89b1d

Urine proteomics-based analysis identifies CHI3L1 as an immune marker and potential therapeutic target for bladder cancer

About this item

Full title

Urine proteomics-based analysis identifies CHI3L1 as an immune marker and potential therapeutic target for bladder cancer

Publisher

England: BioMed Central Ltd

Journal title

BMC cancer, 2025-02, Vol.25 (1), p.271-17

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Bladder cancer (BCa) is a prevalent malignancy characterized by a poor prognosis. Numerous studies have increasingly recognized the role of M2 macrophages in cancer progression. Consequently, our objective is to investigate hub genes in BCa associated with M2 macrophages, assessing their prognostic significance and exploring potential regulatory me...

Alternative Titles

Full title

Urine proteomics-based analysis identifies CHI3L1 as an immune marker and potential therapeutic target for bladder cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_f756f289e2084d27afdb0ae243a89b1d

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f756f289e2084d27afdb0ae243a89b1d

Other Identifiers

ISSN

1471-2407

E-ISSN

1471-2407

DOI

10.1186/s12885-025-13668-1

How to access this item